Kevin Young

EVP, Commercial Operations, Gilead Sciences.

Companies

IRulya Therapeutics Inc.Board member May 8, 2019 to Jun 9, 2020¹
Gilead SciencesChief operating officer May 31, 2016 to Feb 23, 2018²
Gilead SciencesEVP, Commercial Operations Jan 27, 2006 to Feb 4, 2014³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIRulya Therapeutics Inc., Board member
2
SEC EDGARGilead Sciences, Chief operating officer
3
SEC EDGARGilead Sciences, EVP, Commercial Operations